UBC Time-Restricted Eating Study Shows Promise for Overweight Crohn's Patients

Breakthrough in Managing Crohn's Disease: UBC's Time-Restricted Eating Study Unveils Promising Results

A groundbreaking pilot study from the University of British Columbia Okanagan (UBC Okanagan) has revealed that time-restricted eating (TRE), a form of intermittent fasting, can significantly alleviate symptoms in overweight patients living with Crohn's disease. Led by Dr. Natasha Haskey, a registered dietitian and clinical researcher in the School of Health and Exercise Sciences, the research demonstrates reductions in disease activity, inflammation, and body fat composition. This development offers hope for the many Canadians grappling with this chronic inflammatory bowel disease (IBD), particularly those who are overweight, a growing demographic amid rising obesity rates. 30 20

The study, presented as part of recent gastroenterology research, highlights TRE's potential as a sustainable, biology-backed strategy. Participants who confined their meals to a 10-hour daily window experienced notable improvements compared to a control group using a symptom-monitoring app. These findings build on earlier recruitment efforts in British Columbia back in 2023, marking a key milestone in nutritional interventions for IBD. 32

Demystifying Crohn's Disease: Prevalence and Challenges in Canada

Crohn's disease is a type of inflammatory bowel disease characterized by chronic inflammation of the digestive tract, often affecting the small intestine or colon. Symptoms include abdominal pain, severe diarrhea, fatigue, weight loss, and malnutrition. In Canada, IBD affects approximately 1 in 150 people, with Crohn's accounting for a significant portion—estimated at over 100,000 cases nationwide. The condition typically emerges in young adults between 15 and 30 years old, imposing substantial personal, economic, and healthcare burdens.

Compounding the issue, overweight and obesity are increasingly prevalent among IBD patients, affecting 20-40% or more. A multicenter Canadian study found 58% of outpatients with IBD were overweight or obese. This paradox arises partly from treatments like corticosteroids and biologics that promote weight gain, alongside dietary changes and reduced activity due to symptoms. Visceral adipose tissue (VAT), the deep belly fat, exacerbates inflammation, worsening Crohn's flares. 2

The Rise of Overweight in Crohn's Patients: A Canadian Perspective

Statistics Canada data underscores the obesity epidemic's intersection with IBD: over 35% of Canadians are obese, mirroring trends in Crohn's cohorts. In one analysis, obesity rates in IBD patients have climbed from traditional low levels to rival general population figures. This shift complicates management, as excess weight correlates with poorer treatment responses, more frequent hospitalizations, and heightened surgery risks.

For overweight Crohn's patients (body mass index, BMI, greater than 25 kg/m²), achieving remission while losing fat without malnutrition is challenging. Conventional diets often fail due to poor adherence or flare triggers. Enter time-restricted eating, which circumvents calorie counting by leveraging circadian rhythms and metabolic rest periods. 63

What Exactly is Time-Restricted Eating?

Time-restricted eating involves limiting food intake to a specific daily window, typically 8-12 hours, followed by 12-16 hours of fasting (mostly overnight). Unlike intermittent fasting variants like 16:8 or 5:2, TRE emphasizes when you eat rather than what or how much. For example, eating between 9 a.m. and 7 p.m., then fasting until the next morning.

This approach aligns with the body's natural metabolic cycles, promoting autophagy (cellular cleanup), reduced insulin levels, and gut rest. Research suggests TRE lowers inflammation by modulating the gut microbiome and decreasing caloric overload on the digestive system. For IBD patients, it may reduce exposure to irritants during vulnerable nighttime hours. 53

Unpacking the UBC Pilot Study: Methods and Design

The randomized, placebo-controlled pilot trial enrolled 24 adults with mild-to-moderate Crohn's disease and BMI over 25 from British Columbia sites. Participants were split evenly: 12 in the TRE group (10-hour eating window) and 12 in the symptom-monitoring (SM) control group using an app for habit tracking without dietary changes. The intervention lasted 12 weeks, with assessments of Crohn's Disease Activity Index (CDAI), biomarkers like C-reactive protein (CRP), body composition via DEXA scans, and VAT via MRI.

Compliance was high, monitored via apps and food logs. Supported by Crohn's and Colitis Canada, the study addressed a gap: no prior RCTs on TRE specifically for overweight Crohn's patients.Read the full UBC announcement 30

Photo by Milad Fakurian on Unsplash

Key Results: Quantifiable Improvements in Symptoms and Health Markers

The TRE group saw a 40% drop in CDAI scores (from baseline average ~150 to ~90), indicating clinical remission in many, versus a slight increase in controls (p=0.02). CRP, a key inflammation marker, halved in TRE participants while unchanged in SM. Body composition shifted favorably: BMI decreased 3%, total fat mass 5%, VAT 15%—critical for reducing IBD severity.

• Improved insulin sensitivity and lipid profiles
• No adverse events or malnutrition reported
• Gut-specific inflammation (fecal calprotectin) trended down

These outcomes position TRE as adjunctive to medications like anti-TNF therapies. 59

Insights from Lead Researcher Dr. Natasha Haskey

"Our research suggests time-restricted eating may be a sustainable option grounded in biology, offering patients more ways to manage their own health," Haskey stated. A UBC Okanagan faculty member with expertise in microbiome and IBD nutrition, she has previously explored Mediterranean diets and fiber in ulcerative colitis. Her work underscores UBC's commitment to translational research bridging diet and chronic disease. 41

Co-investigators from UBC Vancouver and Calgary clinics emphasize multidisciplinary approaches. Experts like those from the Crohn's & Colitis Foundation praise the trial's rigor, calling for larger studies.Crohn's & Colitis Foundation

For aspiring researchers, opportunities abound in Canada's higher education sector. Explore research jobs or faculty positions at institutions like UBC.

Potential Benefits and Real-World Applications for Patients

• Symptom relief: Less pain, fewer flares through reduced inflammation
• Weight management: Targeted fat loss without muscle wasting
• Metabolic health: Better blood sugar, cholesterol
• Sustainability: Simpler than restrictive diets, high adherence

Patients report easier integration with busy lifestyles. In Canada, where IBD prevalence is among the world's highest, this could ease healthcare strain—IBD costs billions annually.

Risks, Considerations, and When to Consult Professionals

TRE isn't for everyone: underweight patients, pregnant individuals, or those with eating disorders should avoid it. IBD patients risk nutrient gaps, so monitoring by dietitians is essential. Experts recommend starting gradually (12-hour window) and pairing with anti-inflammatory foods.

Dr. Haskey advises: consult gastroenterologists before changes. Ongoing trials explore TRE with biologics. 54

UBC's Pivotal Role in IBD and Nutrition Research

UBC Okanagan and Vancouver campuses lead in health sciences, with centres like the Microbiome and Inflammation Research. Haskey's prior studies on Mediterranean diets show UBC's nutrition focus. For students and professionals, Canadian university jobs and career advice at AcademicJobs.com connect to such impactful work.

This study exemplifies higher education's societal contributions, fostering innovations in patient care.

Photo by Europeana on Unsplash

Future Directions: Larger Trials and Broader Implications

While promising, this pilot needs phase III confirmation. Future research may test 8-hour windows, pediatric applications, or TRE in ulcerative colitis. With Canada's IBD surge, integrating TRE into guidelines could transform management.

Stakeholders—patients, clinicians, policymakers—anticipate scalable solutions. Visit Rate My Professor for insights on UBC faculty or higher ed jobs to join the field.

In conclusion, UBC's time-restricted eating study empowers overweight Crohn's patients with actionable biology. As research evolves, it heralds personalized nutrition's era in IBD care.